Friday Night Inc. (CSE:TGIF,FWB:1QF,OTCQB: TGIFF) is pleased to announce an update to the terms of the Body and Mind letter of intent, and announce a proposed spin out plan for Infused MFG.
Body and Mind LOI
As a result of the negotiations between the parties in respect to the letter of intent (”LOI”) signed with Body and Mind Inc. (”BAM”), the implied value of the BAM shares has been adjusted to an implied value of $1.65 per share or a ratio of 1.65:1 for each BAM share held. Holders of convertible BAM securities will see their options and warrants converted to Friday Night securities with similar terms after taking into account the exchange ratio. The board and management of BAM remains supportive of the transaction notwithstanding the exchange adjustment. The parties anticipate entering into a definitive agreement imminently. The transaction remains subject to BAM shareholder approval and any required regulatory or exchange approvals.
Infused MFG.
Friday Night is also pleased to announce it has reached an agreement in principle with the holder of the 9% interest of its operating subsidiaries in Nevada, AMA and Infused, to acquire the same. The proposed transaction contemplates the exchange of the minority interest in AMA for an interest in Infused MFG., followed by the spin-out of Infused MFG. as a separate publicly traded company. This spin-out would be completed prior to the close of the BAM transaction.
Subject to regulatory approvals and advice from corporate advisors, each Friday Night shareholder will receive 1 Infused MFG. share for each 4 Friday Night shares held. Friday Night has agreed to backstop an initial private placement, so the new company has sufficient cash reserves to both expand and to make strategic acquisitions when available. Final details will be announced when available.
The Company feels that Infused MFG. and their Canna Hemp brand has been successful in building its business and the time is right for a separate management team to expand on its success.
It is a business that could thrive in CBD products alone, so its spin out into a separate company will eliminate for it some of the volatility associated with USA Cannabis based businesses.
About Friday Night Inc.
Friday Night Inc. is a Canadian public company, which owns and controls cannabis and hemp based assets in Las Vegas Nevada. The company owns 91% of Alternative Medicine Association, LC (AMA), a licensed medical and adult-use cannabis cultivation and production facility that produces its own line of unique cannabis-based products and manufactures other third-party brands. Infused MFG, also a 91% owned subsidiary, produces hemp-based, CBD products, thoughtfully crafted of high quality organic botanical ingredients. Friday Night Inc. is focused on strengthening and expanding these operations within and outside of the state.
For further information please contact:
Joe Bleackley, Corporate Communications
604-674-4756
Joe@FridayNightInc.com
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Notice regarding Forward Looking Statements: This news release contains forward-looking statements. The use of any of the words ”anticipate,” ”continue,” ”estimate,” ”expect,” ”may,” ”will,” ”project,” ”should,” ”believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. Friday Night undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law or the Canadian Securities Exchange.
Click here to connect with Friday Night Inc. (CSE:TGIF,FWB:1QF,OTCQB:TGIFF) for an Investor Presentation

Source: www.accesswire.com


Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the Company will have senior management participating in the following virtual financial community conferences and events during December 2020 .

  • Roth Deer Valley Consumer Conference – December 9 th to 11 th , 2020
  • Cantor Fitzgerald 2020 Virtual Cannabis MSO Summit – December 15 th to 16 th , 2020
  • MKM Partners – The Road Ahead, Preparation for 2021 Conference – December 15 th to 16 th , 2020

For more information regarding upcoming Curaleaf financial community conference and event participation please visit the investor relations section of the company website, under the events tab, at https://ir.curaleaf.com/events .

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less